Sheng‐Po Hao

Papers

Total Citations

H-Index

About

Sheng‐Po Hao is a leading voice in head and neck oncology, with a focused expertise in the surgical and multidisciplinary management of oropharyngeal cancer. His major contributions center on defining the evolving role of surgery—particularly trans-oral robotic surgery (TORS)—alongside traditional chemoradiotherapy for both early-stage and advanced oropharyngeal squamous cell carcinoma (OPSCC). In his highly cited narrative reviews, Hao critically evaluates treatment paradigms, demonstrating that while intensity-modulated radiation therapy (IMRT) has been the standard for early-stage disease, TORS offers a promising, less morbid alternative. For advanced OPSCC, he champions a modern approach where primary surgery followed by tailored adjuvant therapy can challenge the long-standing primacy of chemoradiation. His work, which has garnered over a dozen citations in top clinical journals, provides essential, evidence-based guidance for clinicians navigating these complex decisions. By systematically comparing oncologic outcomes and functional preservation, Hao’s research directly impacts how multidisciplinary teams select treatment pathways, making him a key contributor to the ongoing shift toward more personalized, surgical-first strategies in oropharyngeal cancer care.